<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetol Metab Syndr</journal-id><journal-id journal-id-type="iso-abbrev">Diabetol Metab Syndr</journal-id><journal-title-group><journal-title>Diabetology &#x00026; Metabolic Syndrome</journal-title></journal-title-group><issn pub-type="epub">1758-5996</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26759608</article-id><article-id pub-id-type="pmc">4709890</article-id><article-id pub-id-type="publisher-id">118</article-id><article-id pub-id-type="doi">10.1186/s13098-015-0118-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Elevated glycated hemoglobin levels impair blood pressure in children and adolescents with type 1 diabetes mellitus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>de Oliveira</surname><given-names>Sandra</given-names></name><address><email>sandraxoliveira@yahoo.com.br</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>da Cunha Nascimento</surname><given-names>Dahan</given-names></name><address><email>dahanc@hotmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Tibana</surname><given-names>Ramires Alsamir</given-names></name><address><email>ramiires@hotmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>de Oliveira</surname><given-names>Samuel Lima</given-names></name><address><email>samuellimadff@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>de Sousa Neto</surname><given-names>Ivo Vieira</given-names></name><address><email>ivoneto04@hotmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Falleiros</surname><given-names>Roberta Kelly Menezes Maciel</given-names></name><address><email>rkmmaciel@hotmail.com</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Miranda</surname><given-names>Leonardo Garcia</given-names></name><address><email>leosaude@gmail.com</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Pedrosa</surname><given-names>Hermelinda Cordeiro</given-names></name><address><email>pedrosa.hc@globo.com</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Navalta</surname><given-names>James Wilfred</given-names></name><address><email>james.navalta@unlv.edu</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>Guilherme Borges</given-names></name><address><email>guifisiologia@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Prestes</surname><given-names>Jonato</given-names></name><address><phone>(61) 3356-9000</phone><email>jonatop@gmail.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><label/>Department of Physical Education, Graduation Program on Physical Education&#x02014;Catholic University of Brasilia (UCB), Q.S 7, lote 1&#x02014;Bloco G&#x02014;Aguas Claras, Taguatinga, Federal District, Brasilia, DF 71966-700 Brazil </aff><aff id="Aff2"><label/>Endocrinology Unity&#x02014;Research Polo Foundation for Teaching and Research in Health Sciences&#x02014;Regional Hospital of Taguatinga, Federal District, Brasilia, Brazil </aff><aff id="Aff3"><label/>Kinesiology and Nutrition Sciences, University of Nevada, Las Vegas, USA </aff></contrib-group><pub-date pub-type="epub"><day>12</day><month>1</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>12</day><month>1</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>8</volume><elocation-id>4</elocation-id><history><date date-type="received"><day>8</day><month>9</month><year>2015</year></date><date date-type="accepted"><day>23</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; de Oliveira et al. 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Deregulation of glycemic and glycated hemoglobin (HbA<sub>1</sub>) levels accelerate the progression of cardiovascular complications in type 1 diabetes mellitus (T1DM). The aim of this study was to investigate the association between HbA<sub>1</sub> and changes in blood pressure of children and adolescents with T1DM.</p></sec><sec><title>Methods</title><p>A total of 60 children and adolescents were recruited and allocated into two groups (prehypertension and control group). Blood pressure and HbA<sub>1</sub> were measured by the oscillometric method and high-performance liquid chromatography, respectively.</p></sec><sec><title>Results</title><p>The prehypertensive group had (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05) higher disease duration, body weight, Z score for body weight, systolic blood pressure (SBP), diastolic blood pressure (DBP) and a higher HbA<sub>1</sub> when compared with the control children and adolescents. Multiple regression to predict alterations in DBP from HbA<sub>1</sub> adjusted for age, disease duration, and body mass index demonstrated a positive relationship with DBP (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;0.05). A 1&#x000a0;% increase in HbA<sub>1</sub> was associated with 1.73&#x000a0;mmHg increase in DBP.</p></sec><sec><title>Conclusions</title><p>High levels of HbA<sub>1</sub> may be associated with increased blood pressure in T1DM. A tight control of HbA<sub>1</sub> levels may provide long-term cardiovascular protection in children and adolescents with T1DM.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Childhood</kwd><kwd>Cardiovascular health</kwd><kwd>Diabetes</kwd><kwd>Glycated hemoglobin</kwd><kwd>Hypertension</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Type 1 diabetes mellitus (T1DM) is associated with several chronic complications, such as hypertension, nephropathy and dyslipidemia. Furthermore, children with T1DM and hypertension present higher pulse pressure and ambulatory stiffness index levels when compared with normotensive patients [<xref ref-type="bibr" rid="CR1">1</xref>]. Elevated values of blood pressure (BP) in children with T1DM are associated with an increased risk for developing cardiovascular complications later in life [<xref ref-type="bibr" rid="CR1">1</xref>]. Consequently, the early assessment of hypertension, diagnosis, management and treatment is critical in reducing long term microvascular and macrovascular complications [<xref ref-type="bibr" rid="CR2">2</xref>]. Currently, children and adolescents with BP levels of 120/80&#x000a0;mmHg or above, but less than 95th percentile, are classified as prehypertensive [<xref ref-type="bibr" rid="CR3">3</xref>]. Thus, the control of risk factors that might be independently associated with hypertension may improve the care and management of children and adolescents with T1DM [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p>Pietrzak et al. [<xref ref-type="bibr" rid="CR5">5</xref>], investigated the impact of body mass index (BMI) on BP in 164 patients with T1DM aged 14&#x000a0;years. Results revealed a positive correlation of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with age and BMI, while diabetes duration was only correlated with DBP. Although glycated hemoglobin (HbA<sub>1</sub>) was correlated with BMI, this parameter was not used as a main factor to predict BP elevation in T1DM adolescents, which could be a more sensible indicator as compared with BMI. Interestingly, Rohani et al. [<xref ref-type="bibr" rid="CR6">6</xref>], evaluated 62 T1DM patients with HbA<sub>1</sub>&#x000a0;&#x0003c;&#x000a0;7&#x000a0;% and observed that 26&#x000a0;% were in the pre-hypertensive stage. Moreover, elevated BP was correlated with the duration of the disease, but not with HbA<sub>1</sub>. Thus, it seems reasonable to investigate the association of different HbA<sub>1</sub> ranges with BP values in T1DM in children and adolescents.</p><p>In a prospective analysis of 9603 middle-aged participants with and without a previous history of diabetes, Bower et al. [<xref ref-type="bibr" rid="CR7">7</xref>] estimated the association between HbA<sub>1</sub> and hypertension prevalence. Interestingly, subjects with elevated HbA<sub>1</sub> had higher mean fasting glucose, BP, BMI, low density lipoprotein (LDL), cholesterol and triglyceride levels. Furthermore, higher baseline HbA<sub>1</sub> values were associated with increased risk of hypertension during long-term follow-up [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p>Considering that HbA<sub>1</sub>&#x000a0;&#x0003c;&#x000a0;7.5&#x000a0;% is recommended for all pediatric age-groups [<xref ref-type="bibr" rid="CR4">4</xref>], the lack of correlation between BP and HbA<sub>1</sub> in the studies from Rohani et al. [<xref ref-type="bibr" rid="CR6">6</xref>] and Pietrzak et al. [<xref ref-type="bibr" rid="CR5">5</xref>], may be explained by the well-controlled HbA<sub>1</sub> of the patients. Thus, a poor HbA<sub>1</sub> control in T1DM children and adolescents might influence BP.</p><p>In this sense, the aim of the present study was to investigate the association between HbA<sub>1</sub> and changes in BP in T1DM children and adolescents. The initial hypothesis is that the higher HbA<sub>1</sub> levels the higher BP values.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study population</title><p>A total of 60 children and adolescents with an established diagnosis of T1DM [<xref ref-type="bibr" rid="CR2">2</xref>] (age: 12&#x000a0;&#x000b1;&#x000a0;1&#x000a0;years, height: 1.57&#x000a0;&#x000b1;&#x000a0;0.07&#x000a0;m, weight: 48.58&#x000a0;&#x000b1;&#x000a0;8.76&#x000a0;kg, body mass index: 19.63&#x000a0;&#x000b1;&#x000a0;2.96&#x000a0;kg/m<sup>2</sup>, 29 males and 31 females) were recruited from Taguatinga Regional Hospital (Brazil, Brasilia, DF) and participated in the study between February of 2014 and July of 2015.</p><p>Participants were classified as prehypertensive (n&#x000a0;=&#x000a0;22) or normotensive (n&#x000a0;=&#x000a0;38) according to the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood pressure in Children and Adolescents [<xref ref-type="bibr" rid="CR3">3</xref>]. It is now recommended that, as with adults, children and adolescents with blood pressure levels at 120/80&#x000a0;mmHg or above should be considered prehypertensive.</p></sec><sec id="Sec4"><title>Anthropometric and body composition evaluation</title><p>Height was measured using a stadiometer and weight in a scale, and were used for the calculation of the BMI (kg/m<sup>2</sup>). The Z score for weight, height and BMI were used for analysis and were calculated by growth charts (Centers for Disease Control and Prevention, National Center for Health Statistics, 2000) recommended for clinical and research purposes in children and adolescents. Furthermore, overweight and normal weight groups were separated according to the Z score for BMI according to the World Health Organization (WHO) [<xref ref-type="bibr" rid="CR8">8</xref>].</p></sec><sec id="Sec5"><title>Hemodynamic measurements</title><p>Systolic blood pressure, diastolic blood pressure and heart rate (HR) were measured with an oscillometric device (Microlife 3AC1-1, Widnau, Switzerland) according to the recommendations of the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood pressure in Children and Adolescents [<xref ref-type="bibr" rid="CR3">3</xref>]. The cuff size was adapted to the circumference of the arm of each participant according to the manufacture&#x02019;s recommendations. All office BP measures were assessed in triplicate (measurements separated by 1&#x000a0;min) in a calm environment and with an adequate cuff size, with the mean value used for analysis. During BP measurements participants remained seated quietly in a controlled room temperature environment.</p></sec><sec id="Sec6"><title>Blood analysis</title><p>Participants reported to the laboratory between 08:00 and 10:00 a.m., after an overnight fast, and after blood collection, samples were centrifuged at room temperature at 2000&#x000a0;rpm for 15&#x000a0;min. All subjects were encouraged to avoid smoking, alcohol and caffeine consumption as well as unusual physical activity to avoid influence on these parameters. All patients provided blood samples and the concentration of glucose (mg/dL), HbA<sub>1</sub> (%), high density lipoprotein (HDL), LDL, triglycerides and total cholesterol were measured. Glucose and HbA<sub>1</sub> were measured by high-performance liquid chromatography (Bio-Rad, Brazil). The lipid profile was measured by an enzymatic colorimetric method on autohumalyzer equipment (Human GMBH, Germany). High density lipoprotein was determined by ionic exchange followed by colorimetric reaction with the Linco Research Inc. kit (St Louis, USA).</p></sec><sec id="Sec7"><title>Statistical analysis</title><p>The results are expressed as mean and standard deviation (SD). The Shapiro&#x02013;Wilk test was used to analyze the normality of the data. For comparisons between groups, an independent-<italic>t</italic> test was applied and for non-parametric data the Mann&#x02013;Whitney test was used. A bivariate correlation using Pearson&#x02019;s test was used to assess the correlation between age, disease duration, HbA<sub>1</sub> and BMI with BP as the main outcome [<xref ref-type="bibr" rid="CR9">9</xref>]. The strength and magnitude of the correlation between variables was classified as follows [<xref ref-type="bibr" rid="CR10">10</xref>]:&#x000a0;&#x000b1;1.0 perfect,&#x000a0;&#x000b1;0.7 to&#x000a0;&#x000b1;0.9 strong,&#x000a0;&#x000b1;0.4 to&#x000a0;&#x000b1;0.6 moderate,&#x000a0;&#x000b1;0.1 to &#x000a0;&#x000b1;0.3 weak and 0 zero. After that, a multiple regression analysis was performed and BP was analyzed as the dependent variable and adjusted for several confounding variables, such as age, disease duration, and BMI [<xref ref-type="bibr" rid="CR5">5</xref>]. Significance was accepted at the <italic>P</italic>&#x000a0;&#x02264;&#x000a0;0.05 and analyses were conducted with SPSS version 18.0 (SPSS Inc., Chicago).</p><p>The study was approved by the <italic>Funda&#x000e7;&#x000e3;o de Ensino e Pesquisa em Ci&#x000ea;ncias da Sa&#x000fa;de</italic> (n&#x000ba; 710.782) and approved by the Institutional Research Ethics Comitte of Catholic University of Brasilia (n&#x000ba; 681.469) in accordance with the declaration of Helsinki. Informed consent was obtained from parents and informed assent from children and adolescents.</p></sec></sec><sec id="Sec8"><title>Results</title><p>Descriptive characteristics of the study participants are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The prehypertensive group demonstrated significantly higher T1DM disease duration, body weight, Z score body weight, SBP, DBP and HbA<sub>1</sub> as compared with the normotensive group of children and adolescents with T1DM, although no differences were verified for BMI z-score (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The analysis according to gender revealed that female individuals displayed a higher basal HR when compared with the male individuals, with no differences for anthropometric and biochemical variables (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). In addition, children&#x02019;s were divided into overweight and normal body weight. There was no significant difference (<italic>P</italic>&#x000a0;=&#x000a0;0.619) in SBP when groups were separated for overweight (114.3&#x000a0;&#x000b1;1.3&#x000a0;mmHg) and normal body weight (112.4&#x000a0;&#x000b1;&#x000a0;1.16&#x000a0;mmHg). However, there was a tendency toward statistical significance (<italic>P</italic>&#x000a0;=&#x000a0;0.052) for DBP between overweight (75.5&#x000a0;&#x000b1;&#x000a0;3.33&#x000a0;mmHg) and the normal body weight (68.6&#x000a0;&#x000b1;&#x000a0;1.4) group (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Differences between groups and gender demonstrated by means and standard deviation (SD)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Normotensive</th><th align="left">Prehypertension</th><th align="left">
<italic>P</italic>
</th><th align="left">
<italic>P</italic>
<sup>b</sup>
</th><th align="left">Boys</th><th align="left">
<bold>Girls</bold>
</th></tr></thead><tbody><tr><td align="left">Disease duration, years</td><td align="left">5.32&#x000a0;&#x000b1;&#x000a0;3.62</td><td align="left">7.54&#x000a0;&#x000b1;&#x000a0;3.78*</td><td char="." align="char">0.029</td><td char="." align="char">0.758</td><td align="left">6.31&#x000a0;&#x000b1;&#x000a0;4.26</td><td align="left">6.00&#x000a0;&#x000b1;&#x000a0;3.38</td></tr><tr><td align="left">Age, years</td><td align="left">12.78&#x000a0;&#x000b1;&#x000a0;1.16</td><td align="left">13.27&#x000a0;&#x000b1;&#x000a0;1.20</td><td char="." align="char">0.132</td><td char="." align="char">0.132</td><td align="left">13.20&#x000a0;&#x000b1;&#x000a0;1.36</td><td align="left">12.74&#x000a0;&#x000b1;&#x000a0;0.99</td></tr><tr><td align="left">Body weight, kg</td><td align="left">46.40&#x000a0;&#x000b1;&#x000a0;9.04</td><td align="left">52.38&#x000a0;&#x000b1;&#x000a0;6.90*</td><td char="." align="char">0.013</td><td char="." align="char">0.852</td><td align="left">48.35&#x000a0;&#x000b1;&#x000a0;8.09</td><td align="left">48.80&#x000a0;&#x000b1;&#x000a0;9.50</td></tr><tr><td align="left">Height, cm</td><td align="left">1.56&#x000a0;&#x000b1;&#x000a0;0.06</td><td align="left">1.59&#x000a0;&#x000b1;&#x000a0;0.07</td><td char="." align="char">0.082</td><td char="." align="char">0.077</td><td align="left">1.59&#x000a0;&#x000b1;&#x000a0;0.07</td><td align="left">1.55&#x000a0;&#x000b1;&#x000a0;0.06</td></tr><tr><td align="left">Body mass index, kg/m<sup>2</sup>
</td><td align="left">19.09&#x000a0;&#x000b1;&#x000a0;3.10</td><td align="left">20.58&#x000a0;&#x000b1;&#x000a0;2.48</td><td char="." align="char">0.080</td><td char="." align="char">0.172</td><td align="left">19.07&#x000a0;&#x000b1;&#x000a0;2.30</td><td align="left">20.20&#x000a0;&#x000b1;&#x000a0;3.45</td></tr><tr><td align="left">Z score body weight<sup>a</sup>
</td><td align="left">&#x02212;0.57 (&#x02212;4.72 to 1.62)</td><td align="left">0.05 (&#x02212;1.63 to 1.33)*</td><td char="." align="char">0.042</td><td char="." align="char">0.731</td><td align="left">&#x02212;0.11 (&#x02212;4.72 to 1.62)</td><td align="left">&#x02212;0.50 (&#x02212;2.15 to 1.34)</td></tr><tr><td align="left">Z score height<sup>a</sup>
</td><td align="left">&#x02212;0.73 (&#x02212;1.89 to 1.68)</td><td align="left">&#x02212;0.21 (&#x02212;2.21 to 1.18)</td><td char="." align="char">0.154</td><td char="." align="char">0.747</td><td align="left">&#x02212;0.68 (&#x02212;1.75 to 1.18)</td><td align="left">&#x02212;0.40 (&#x02212;2.21 to 1.68)</td></tr><tr><td align="left">Z score body mass index<sup>a</sup>
</td><td align="left">&#x02212;0.03 (&#x02212;4.72 to 1.58)</td><td align="left">0.23 (&#x02212;0.95 to 1.17)</td><td char="." align="char">0.213</td><td char="." align="char">0.642</td><td align="left">0.04 (&#x02212;1.69 to 1.41)</td><td align="left">0.15 (&#x02212;4.72 to 1.58)</td></tr><tr><td align="left">SBP, mmHg</td><td align="left">107.86&#x000a0;&#x000b1;&#x000a0;7.32</td><td align="left">122.59&#x000a0;&#x000b1;&#x000a0;6.88*</td><td char="." align="char">0.001</td><td char="." align="char">0.498</td><td align="left">112.34&#x000a0;&#x000b1;&#x000a0;11.83</td><td align="left">114.12&#x000a0;&#x000b1;&#x000a0;8.22</td></tr><tr><td align="left">DBP, mmHg</td><td align="left">66.39&#x000a0;&#x000b1;&#x000a0;5.49</td><td align="left">77.04&#x000a0;&#x000b1;&#x000a0;10.59*</td><td char="." align="char">0.001</td><td char="." align="char">0.272</td><td align="left">68.93&#x000a0;&#x000b1;&#x000a0;9.83</td><td align="left">71.58&#x000a0;&#x000b1;&#x000a0;8.64</td></tr><tr><td align="left">HR, bpm</td><td align="left">86.83&#x000a0;&#x000b1;&#x000a0;15.001</td><td align="left">92.27&#x000a0;&#x000b1;&#x000a0;18.12</td><td char="." align="char">0.221</td><td char="." align="char">0.024*</td><td align="left">83.92&#x000a0;&#x000b1;&#x000a0;15.22</td><td align="left">95.53&#x000a0;&#x000b1;&#x000a0;16.17</td></tr><tr><td align="left">Glycaemia, mg/dl</td><td align="left">215.47&#x000a0;&#x000b1;&#x000a0;90.91</td><td align="left">204.00&#x000a0;&#x000b1;&#x000a0;113.03</td><td char="." align="char">0.752</td><td char="." align="char">0.978</td><td align="left">212.15&#x000a0;&#x000b1;&#x000a0;82.62</td><td align="left">211.21&#x000a0;&#x000b1;&#x000a0;117.94</td></tr><tr><td align="left">HbA<sub>1</sub>, &#x000a0;%</td><td align="left">9.74&#x000a0;&#x000b1;&#x000a0;1.98</td><td align="left">11.58&#x000a0;&#x000b1;&#x000a0;3.08*</td><td char="." align="char">0.037</td><td char="." align="char">0.573</td><td align="left">10.17&#x000a0;&#x000b1;&#x000a0;2.46</td><td align="left">10.60&#x000a0;&#x000b1;&#x000a0;2.67</td></tr><tr><td align="left">HDL, mg/dl</td><td align="left">54.47&#x000a0;&#x000b1;&#x000a0;8.45</td><td align="left">51.14&#x000a0;&#x000b1;&#x000a0;12.22</td><td char="." align="char">0.333</td><td char="." align="char">0.782</td><td align="left">52.80&#x000a0;&#x000b1;&#x000a0;8.48</td><td align="left">53.75&#x000a0;&#x000b1;&#x000a0;12.00</td></tr><tr><td align="left">LDL, mg/dl</td><td align="left">102.22&#x000a0;&#x000b1;&#x000a0;25.78</td><td align="left">102.50&#x000a0;&#x000b1;&#x000a0;38.72</td><td char="." align="char">0.979</td><td char="." align="char">0.814</td><td align="left">103.39&#x000a0;&#x000b1;&#x000a0;30.86</td><td align="left">100.93&#x000a0;&#x000b1;&#x000a0;31.63</td></tr><tr><td align="left">Triglycerides, mg/dl</td><td align="left">89.44&#x000a0;&#x000b1;&#x000a0;40.29</td><td align="left">92.53&#x000a0;&#x000b1;&#x000a0;44.39</td><td char="." align="char">0.820</td><td char="." align="char">0.138</td><td align="left">81.91&#x000a0;&#x000b1;&#x000a0;38.10</td><td align="left">101.00&#x000a0;&#x000b1;&#x000a0;43.57</td></tr><tr><td align="left">Total cholesterol, mg/dl</td><td align="left">169.78&#x000a0;&#x000b1;&#x000a0;39.06</td><td align="left">177.00&#x000a0;&#x000b1;&#x000a0;38.67</td><td char="." align="char">0.566</td><td char="." align="char">0.750</td><td align="left">170.52&#x000a0;&#x000b1;&#x000a0;44.92</td><td align="left">174.35&#x000a0;&#x000b1;&#x000a0;30.87</td></tr></tbody></table><table-wrap-foot><p>
<italic>SBP</italic> systolic blood pressure, <italic>DBP</italic> diastolic blood pressure, <italic>HR</italic> heart rate, <italic>HbA</italic>
<sub><italic>1</italic></sub> glycated hemoglobin</p><p>* <italic>P</italic>&#x000a0;&#x02264;&#x000a0;0.05</p><p>
<sup><bold>a</bold></sup>Data not normally distributed is presented as median, minimum and maximum values</p><p>
<sup><bold>b</bold></sup> Comparisons between sexes</p></table-wrap-foot></table-wrap><fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Systolic blood pressure (SBP) and diastolic blood pressure (DBP) between overweight and normal body weight children and adolescents with T1DM. Data presented as means and standard deviation (SD)</p></caption><graphic xlink:href="13098_2015_118_Fig1_HTML" id="MO1"/></fig></p><p>Although not statistically significant, there was a positive weak correlation between age, diagnosis time, HbA<sub>1</sub> and BMI with blood pressure. In addition, DBP and HbA<sub>1</sub> demonstrated a positive, significant, and moderate correlation (values of&#x000a0;&#x000b1;&#x000a0;0.5; Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Correlation between blood pressure and age, disease duration, HbA<sub>1</sub> and body mass index</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Parameter</th><th align="left">Systolic blood pressure</th><th align="left">
<italic>P</italic>
</th><th align="left">Diastolic blood pressure</th><th align="left">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left">Disease duration, years</td><td align="left">
<italic>R</italic>&#x000a0;=&#x000a0;0.13</td><td char="." align="char">0.297</td><td align="left">
<italic>R</italic>&#x000a0;=&#x000a0;0.00</td><td char="." align="char">0.960</td></tr><tr><td align="left">Age, years</td><td align="left">
<italic>R</italic>&#x000a0;=&#x000a0;0.12</td><td char="." align="char">0.326</td><td align="left">
<italic>R</italic>&#x000a0;=&#x000a0;0.20</td><td char="." align="char">0.113</td></tr><tr><td align="left">Body mass index, kg/m<sup>2</sup>
</td><td align="left">
<italic>R</italic>&#x000a0;=&#x000a0;0.24</td><td char="." align="char">0.081</td><td align="left">
<italic>R</italic>&#x000a0;=&#x000a0;0.21</td><td char="." align="char">0.113</td></tr><tr><td align="left">HbA<sub>1</sub>, &#x000a0;%</td><td align="left">
<italic>R</italic>&#x000a0;=&#x000a0;0.24</td><td char="." align="char">0.089</td><td align="left">
<italic>R</italic>&#x000a0;=&#x000a0;0.54*</td><td char="." align="char">0.001</td></tr></tbody></table><table-wrap-foot><p>
<italic>HbA</italic>
<sub><italic>1</italic></sub> glycated hemoglobin</p><p>* <italic>P</italic>&#x000a0;&#x02264;&#x000a0;0.05</p></table-wrap-foot></table-wrap></p><p>Following the correlational analysis, a multiple regression was run to predict alterations on DBP from HbA<sub>1</sub> adjusted for age, diagnosis time, and BMI (categorical variable used to allocate children and adolescents into eutrophic and overweight according to BMI cutoffs for teenagers and children [<xref ref-type="bibr" rid="CR8">8</xref>]). The model significantly predicted DBP (CI 95&#x000a0;% for Beta between 0.68 and 2.78, <italic>P</italic>&#x000a0;=&#x000a0;0.003), and HbA<sub>1</sub> demonstrated a positive correlation with DBP. According to this model, each 1&#x000a0;% increase in HbA<sub>1</sub> is associated with an increase of 1.73&#x000a0;mmHg in DBP (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). For SBP the regression, the adjusted model for the same covariates used in DBP was assessed, and the model did not improve the ability to predict the outcome variable (<italic>P</italic>&#x000a0;=&#x000a0;0.11).<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Correlation between HbA<sub>1</sub> and diastolic blood pressure adjusted for age, disease duration, and body mass index</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Variable</th><th align="left">
<italic>B</italic>
</th><th align="left">
<italic>SE</italic>
<sub><italic>B</italic></sub>
</th><th align="left">
<italic>&#x003b2;</italic>
</th><th align="left">
<italic>P</italic>
</th></tr></thead><tbody><tr><td align="left">Intercept</td><td char="." align="char">29.11</td><td char="." align="char">14.80</td><td align="left"/><td char="." align="char">0.058</td></tr><tr><td align="left">HbA<sub>1</sub>, &#x000a0;%<sup>a</sup>
</td><td char="." align="char">1.73</td><td char="." align="char">0.51</td><td char="." align="char">0.48</td><td char="." align="char">0.002*</td></tr></tbody></table><table-wrap-foot><p>
<sup>a</sup>Adjusted for age, disease duration and body mass index</p><p>
<italic>HbA</italic>
<sub><italic>1</italic></sub> glycated hemoglobin</p><p>* <italic>P</italic>&#x000a0;&#x02264;&#x000a0;0.05</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>Discussion</title><p>There are relatively few studies investigating the impact of HbA<sub>1</sub> on BP in children and adolescents with T1DM. A multiple regression analysis with adjustment for age, T1DM disease duration and BMI revealed a positive correlation between DBP and HbA<sub>1</sub>. In addition, this study demonstrated that prehypertensive children and adolescents with T1DM presented increased time of disease duration, as well as higher SBP, DBP and HbA<sub>1</sub> values.</p><p>Moreover, comparisons between gender were made in this study, because it is an important predictor of the alteration in carotid artery intima-media-thickness and there is a relationship between CCA and IMT and established cardiovascular disease risk factors, such as hypertension and the quality of the metabolic glycemic control (estimated by HbA<sub>1</sub>) in children and adolescents with T1DM [<xref ref-type="bibr" rid="CR11">11</xref>]. In addition, in a previous study, boys with T1DM presented higher fasting glucose, lower intima-media-thickness and a lower body mass index (kg/m<sup>2</sup>) when compared with girls with T1DM [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p>The results of this study revealed that HbA<sub>1</sub> presented a positive correlation with DBP, even adjusted for several confounding variables, such as age, disease duration, and BMI, while no correlation was found with SBP. These results are relevant because, each 1&#x000a0;% increase in HbA<sub>1</sub> is associated with an increase of 1.73&#x000a0;mmHg in DBP. This increment, although small, can augment the risk of stroke by 14-17 %, and risk of coronary artery disease by 6-9 %, in the general population [<xref ref-type="bibr" rid="CR12">12</xref>].</p><p>The benefits of better BP and lipid levels control were clearly demonstrated by an observational prospective study of 589 patients with childhood-onset T1DM (&#x0003c;17&#x000a0;years) [<xref ref-type="bibr" rid="CR13">13</xref>]. Higher values for SBP, DBP and lipid levels were associated with higher relative risks for mortality, coronary artery disease and nephropathy. Furthermore, even a small reduction of 2&#x000a0;mmHg in DBP, for example, can have a great impact in terms of number of cardiovascular events prevented, such as coronary heart disease and stroke [<xref ref-type="bibr" rid="CR14">14</xref>].</p><p>Nevertheless, hyperglycemia (evaluated by HbA<sub>1</sub>) that is intimately related with glycemic control, plays an important role in the development of microvascular complications [<xref ref-type="bibr" rid="CR15">15</xref>] [<xref ref-type="bibr" rid="CR13">13</xref>]. The levels of HbA<sub>1</sub> in children and adolescents with T1DM of the present study were higher than the &#x0003c;7.5&#x000a0;% recommended across all pediatric age-groups. Moreover, there is an association of high HbA<sub>1</sub> levels with hyperglycemia, dyslipidemia and hyperinsulinemia, which mediates vascular dysfunction, activation of the renin-angiotensin-aldosterone system, sympathetic nervous system, and possibly negative alterations in BP [<xref ref-type="bibr" rid="CR16">16</xref>]. It appears that a lack of association between HbA<sub>1</sub> and BP in previous studies [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>] might be explained by the well-controlled HbA<sub>1</sub> levels of children and adolescents with T1DM.</p><p>Moreover, when comparing children and adolescents with T1DM to obese children and adolescents without T1DM, BP depends on BMI [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. When groups were separated according to Z score for BMI [<xref ref-type="bibr" rid="CR8">8</xref>] [<xref ref-type="bibr" rid="CR8">8</xref>], mean BP values in the groups of patients classified as overweight were higher, but not statistically significant different when compared with the normal body weight group (SBP&#x000a0;=&#x000a0;114.25&#x000a0;&#x000b1;&#x000a0;3.84 vs. 112.44&#x000a0;&#x000b1;&#x000a0;9.96; DBP&#x000a0;=&#x000a0;75.50&#x000a0;&#x000b1;&#x000a0;9.42 vs. 68.60&#x000a0;&#x000b1;&#x000a0;8.76 for overweight and normal body mass, respectively).</p><p>In addition, prehypertensive children and adolescents with T1DM displayed a longer disease duration and higher BP. Nonetheless, Wigmann et al. [<xref ref-type="bibr" rid="CR19">19</xref>], found that the elevation of BP, albuminuria, and renal dysfunction were altered in parallel when comparing groups with increased disease duration in 166 T1DM patients aged 25&#x000a0;years. These results suggest that disease duration of T1DM is an interesting topic of research to pursue in further investigations.</p><p>The values of glycemic control in this study are similar to the study from Ngwiri et al. [<xref ref-type="bibr" rid="CR20">20</xref>], where children and adolescents with T1DM from Sub-Saharam Africa presented a median HbA<sub>1</sub> of 11&#x000a0;%. An interesting result was that age above 12&#x000a0;years was significantly associated with poor glycemic control. The poor glycemic control reported in this study is far from being acceptable and most of the participants of this study might present a high risk for the precocious development of microvascular complications. Therefore, this data strongly reinforce the importance of counseling children and adolescents with T1DM regarding management, follow-up, and more resources should be provided on care of this disease. We agree that the education and follow-up of children and adolescents with T1DM must be analyzed according to economic status, educational level, social level, and available resources. Another important topic to be considered is the viability of educational methods for professionals and the institutions involved. The programs must be coherent as the feasibility, scope, access, cost-effective and proposed goals, and should be adapted according to the health system [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p>It should be noted that this study presents some limitations. Diabetes education differs from country to country, and the control of educational strategies by parents and their children regarding HbA<sub>1</sub> values that help to prevent long term micro- and macrovascular complications were not controlled in this study. We are aware that education variables in the location where the present study was conducted could be more personalized. However, proper diabetes education for children and adolescents with T1DM, and their family is a complex condition, which requires educators with a set of skills including good communication, compassion, sensitivity, humor, and in-depth knowledge of childhood diabetes [<xref ref-type="bibr" rid="CR2">2</xref>]. Furthermore, the lack of controlled maturational status [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], daily dose of insulin prescribed, renal status, and physical activity [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>] might be important confounding factors that should be analyzed in future studies.</p></sec><sec id="Sec10"><title>Conclusions</title><p>A poor glycemic control might represent an important factor to be controlled by educational programs as a strategy to prevent hypertension and associated long-term cardiovascular problems in children and adolescents with T1DM. Health behaviors, such as appropriate nutrition and exercise should be recommended as an adjunct to the prescribed medication therapy.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>HbA<sub>1</sub></term><def><p>glycated hemoglobin</p></def></def-item><def-item><term>T1DM</term><def><p>type 1 diabetes mellitus</p></def></def-item><def-item><term>SBP</term><def><p>systolic blood pressure</p></def></def-item><def-item><term>DBP</term><def><p>diastolic blood pressure</p></def></def-item><def-item><term>BMI</term><def><p>body mass index</p></def></def-item><def-item><term>BP</term><def><p>blood pressure</p></def></def-item><def-item><term>LDL</term><def><p>low density lipoprotein</p></def></def-item><def-item><term>HR</term><def><p>heart rate</p></def></def-item><def-item><term>HDL</term><def><p>high density lipoprotein</p></def></def-item><def-item><term>SD</term><def><p>standard deviation</p></def></def-item></def-list></glossary><ack><title>Authors&#x02019; contributions</title><p>SO, DCN, RAT, RKMMF, HCP, GBP, JWN and JP were responsible for concept and design, statistical expertise, data analysis and interpretation, helped write the manuscript. SLO, IVSN and LGM were significant manuscript reviewers/revisers and were responsible for data collections. All authors read and approved the final manuscript.</p><sec id="FPar1"><title>Competing interests</title><p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declare that they have no competing interests.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulakova</surname><given-names>T</given-names></name><name><surname>Janda</surname><given-names>J</given-names></name><name><surname>Cerna</surname><given-names>J</given-names></name><name><surname>Janstova</surname><given-names>V</given-names></name><name><surname>Feber</surname><given-names>J</given-names></name></person-group><article-title>Assessment of arterial stiffness from ambulatory blood pressure monitoring in children with diabetes mellitus type-1 (DMT1)</article-title><source>J Hum Hypertens</source><year>2012</year><volume>26</volume><issue>6</issue><fpage>357</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1038/jhh.2011.38</pub-id><pub-id pub-id-type="pmid">21544085</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverstein</surname><given-names>J</given-names></name><name><surname>Klingensmith</surname><given-names>G</given-names></name><name><surname>Copeland</surname><given-names>K</given-names></name><name><surname>Plotnick</surname><given-names>L</given-names></name><name><surname>Kaufman</surname><given-names>F</given-names></name><name><surname>Laffel</surname><given-names>L</given-names></name><etal/></person-group><article-title>Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association</article-title><source>Diab Care</source><year>2005</year><volume>28</volume><issue>1</issue><fpage>186</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.2337/diacare.28.1.186</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555&#x02013;76. doi:10.1542/peds.114.2.S2.555.</mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Children and adolescents. Diab Care. 2015;38(SupplS70&#x02013;S76). doi:10.2337/dc15-S014.</mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietrzak</surname><given-names>I</given-names></name><name><surname>Mianowska</surname><given-names>B</given-names></name><name><surname>Gadzicka</surname><given-names>A</given-names></name><name><surname>Mlynarski</surname><given-names>W</given-names></name><name><surname>Szadkowska</surname><given-names>A</given-names></name></person-group><article-title>Blood pressure in children and adolescents with type 1 diabetes mellitus&#x02013;the influence of body mass index and fat mass</article-title><source>Pediatr Endocrinol Diab Metab</source><year>2009</year><volume>15</volume><issue>4</issue><fpage>240</fpage><lpage>245</lpage></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohani</surname><given-names>F</given-names></name><name><surname>Hooman</surname><given-names>N</given-names></name><name><surname>Moradi</surname><given-names>S</given-names></name><name><surname>Mobarra</surname><given-names>M</given-names></name><name><surname>Najafizadeh</surname><given-names>M</given-names></name><name><surname>Tatarpoor</surname><given-names>P</given-names></name></person-group><article-title>The Prevalence of Pre-hypertension in children with type 1 diabetes mellitus</article-title><source>Int J Prev Med</source><year>2014</year><volume>5</volume><issue>Suppl 1</issue><fpage>S44</fpage><lpage>S49</lpage><pub-id pub-id-type="pmid">24791191</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bower</surname><given-names>JK</given-names></name><name><surname>Appel</surname><given-names>LJ</given-names></name><name><surname>Matsushita</surname><given-names>K</given-names></name><name><surname>Young</surname><given-names>JH</given-names></name><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Brancati</surname><given-names>FL</given-names></name><etal/></person-group><article-title>Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study</article-title><source>Diab Care</source><year>2012</year><volume>35</volume><issue>5</issue><fpage>1031</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.2337/dc11-2248</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Onis</surname><given-names>M</given-names></name><name><surname>Onyango</surname><given-names>AW</given-names></name><name><surname>Borghi</surname><given-names>E</given-names></name><name><surname>Siyam</surname><given-names>A</given-names></name><name><surname>Nishida</surname><given-names>C</given-names></name><name><surname>Siekmann</surname><given-names>J</given-names></name></person-group><article-title>Development of a WHO growth reference for school-aged children and adolescents</article-title><source>Bull World Health Organ</source><year>2007</year><volume>85</volume><issue>9</issue><fpage>660</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.2471/BLT.07.043497</pub-id><pub-id pub-id-type="pmid">18026621</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Field AP. Discovering statistics using IBM SPSS statistics: and sex and drugs and rock &#x02018;n&#x02019; roll. 4th ed.</mixed-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dancey</surname><given-names>CP</given-names></name><name><surname>Reidy</surname><given-names>J</given-names></name></person-group><source>Statistics without maths for psychology</source><year>2011</year><edition>5</edition><publisher-loc>Harlow, England; New York</publisher-loc><publisher-name>Prentice Hall/Pearson</publisher-name></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giurgea</surname><given-names>GA</given-names></name><name><surname>Nagl</surname><given-names>K</given-names></name><name><surname>Gschwandtner</surname><given-names>M</given-names></name><name><surname>Hobaus</surname><given-names>C</given-names></name><name><surname>Hortenhuber</surname><given-names>T</given-names></name><name><surname>Koppensteiner</surname><given-names>R</given-names></name><etal/></person-group><article-title>Gender, metabolic control and carotid intima-media-thickness in children and adolescents with type 1 diabetes mellitus</article-title><source>Wien Klin Wochenschr</source><year>2015</year><volume>127</volume><issue>3&#x02013;4</issue><fpage>116</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1007/s00508-014-0640-3</pub-id><pub-id pub-id-type="pmid">25412591</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pescatello</surname><given-names>LS</given-names></name><name><surname>Franklin</surname><given-names>BA</given-names></name><name><surname>Fagard</surname><given-names>R</given-names></name><name><surname>Farquhar</surname><given-names>WB</given-names></name><name><surname>Kelley</surname><given-names>GA</given-names></name><name><surname>Ray</surname><given-names>CA</given-names></name></person-group><article-title>American College of Sports Medicine position stand. Exercise and hypertension</article-title><source>Med Sci Sports Exerc</source><year>2004</year><volume>36</volume><issue>3</issue><fpage>533</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1249/01.MSS.0000115224.88514.3A</pub-id><pub-id pub-id-type="pmid">15076798</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orchard</surname><given-names>TJ</given-names></name><name><surname>Forrest</surname><given-names>KY</given-names></name><name><surname>Kuller</surname><given-names>LH</given-names></name><name><surname>Becker</surname><given-names>DJ</given-names></name></person-group><article-title>Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study</article-title><source>Diab Care</source><year>2001</year><volume>24</volume><issue>6</issue><fpage>1053</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.2337/diacare.24.6.1053</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Cohen</surname><given-names>J</given-names></name><name><surname>Hebert</surname><given-names>PR</given-names></name><name><surname>Taylor</surname><given-names>JO</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name></person-group><article-title>Implications of small reductions in diastolic blood pressure for primary prevention</article-title><source>Arch Intern Med</source><year>1995</year><volume>155</volume><issue>7</issue><fpage>701</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1001/archinte.1995.00430070053006</pub-id><pub-id pub-id-type="pmid">7695458</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiarelli</surname><given-names>F</given-names></name><name><surname>Trotta</surname><given-names>D</given-names></name><name><surname>Verrotti</surname><given-names>A</given-names></name><name><surname>Mohn</surname><given-names>A</given-names></name></person-group><article-title>Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus</article-title><source>Pediatr Diabetes.</source><year>2002</year><volume>3</volume><issue>2</issue><fpage>113</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1034/j.1399-5448.2002.30209.x</pub-id><pub-id pub-id-type="pmid">15016166</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>BM</given-names></name><name><surname>Li</surname><given-names>C</given-names></name></person-group><article-title>Diabetes and hypertension: is there a common metabolic pathway?</article-title><source>Curr Atheroscler Rep.</source><year>2012</year><volume>14</volume><issue>2</issue><fpage>160</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1007/s11883-012-0227-2</pub-id><pub-id pub-id-type="pmid">22281657</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grober-Gratz</surname><given-names>D</given-names></name><name><surname>Widhalm</surname><given-names>K</given-names></name><name><surname>de Zwaan</surname><given-names>M</given-names></name><name><surname>Reinehr</surname><given-names>T</given-names></name><name><surname>Bluher</surname><given-names>S</given-names></name><name><surname>Schwab</surname><given-names>KO</given-names></name><etal/></person-group><article-title>Body mass index or waist circumference: which is the better predictor for hypertension and dyslipidemia in overweight/obese children and adolescents? Association of cardiovascular risk related to body mass index or waist circumference</article-title><source>Horm Res Paediatr.</source><year>2013</year><volume>80</volume><issue>3</issue><fpage>170</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1159/000354224</pub-id><pub-id pub-id-type="pmid">24021483</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plachta-Danielzik</surname><given-names>S</given-names></name><name><surname>Landsberg</surname><given-names>B</given-names></name><name><surname>Johannsen</surname><given-names>M</given-names></name><name><surname>Lange</surname><given-names>D</given-names></name><name><surname>Muller</surname><given-names>MJ</given-names></name></person-group><article-title>Association of different obesity indices with blood pressure and blood lipids in children and adolescents</article-title><source>Br J Nutr</source><year>2008</year><volume>100</volume><issue>1</issue><fpage>208</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1017/S0007114508882980</pub-id><pub-id pub-id-type="pmid">18346303</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiegmann</surname><given-names>TB</given-names></name><name><surname>Chonko</surname><given-names>AM</given-names></name><name><surname>MacDougall</surname><given-names>ML</given-names></name><name><surname>Moore</surname><given-names>WV</given-names></name></person-group><article-title>The role of disease duration and hypertension in albumin excretion of type I diabetes mellitus</article-title><source>J Am Soc Nephrol</source><year>1992</year><volume>2</volume><issue>11</issue><fpage>1587</fpage><lpage>1592</lpage><pub-id pub-id-type="pmid">1610979</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngwiri</surname><given-names>T</given-names></name><name><surname>Were</surname><given-names>F</given-names></name><name><surname>Predieri</surname><given-names>B</given-names></name><name><surname>Ngugi</surname><given-names>P</given-names></name><name><surname>Iughetti</surname><given-names>L</given-names></name></person-group><article-title>Glycemic Control in Kenyan Children and Adolescents with Type 1 Diabetes Mellitus</article-title><source>Int J Endocrinol</source><year>2015</year><pub-id pub-id-type="pmid">26494998</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leite</surname><given-names>SAO</given-names></name><name><surname>Zanim</surname><given-names>LM</given-names></name><name><surname>Granzotto</surname><given-names>PCD</given-names></name><name><surname>Heupa</surname><given-names>S</given-names></name><name><surname>Lamounier</surname><given-names>RN</given-names></name></person-group><article-title>Educational program to type 1 diabetes mellitus patients: basic topics</article-title><source>Arq Bras Endocrinol Metab.</source><year>2008</year><volume>52</volume><issue>2</issue><fpage>233</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1590/S0004-27302008000200010</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>YH</given-names></name><name><surname>Craig</surname><given-names>ME</given-names></name><name><surname>Donaghue</surname><given-names>KC</given-names></name></person-group><article-title>Puberty as an accelerator for diabetes complications</article-title><source>Pediatr Diabetes.</source><year>2014</year><volume>15</volume><issue>1</issue><fpage>18</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1111/pedi.12112</pub-id><pub-id pub-id-type="pmid">24443957</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>DG</given-names></name><name><surname>White</surname><given-names>NH</given-names></name><name><surname>Shalwitz</surname><given-names>RA</given-names></name><name><surname>Palmberg</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>ME</given-names></name><name><surname>Santiago</surname><given-names>JV</given-names></name></person-group><article-title>The effect of puberty on the development of early diabetic microvascular disease in insulin-dependent diabetes</article-title><source>Diab Res Clin Pract</source><year>1987</year><volume>3</volume><issue>1</issue><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/S0168-8227(87)80006-2</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques Rde</surname><given-names>M</given-names></name><name><surname>Fornes</surname><given-names>NS</given-names></name><name><surname>Stringhini</surname><given-names>ML</given-names></name></person-group><article-title>Socioeconomic, demographic, nutritional, and physical activity factors in the glycemic control of adolescents with type 1 diabetes mellitus</article-title><source>Arq Bras Endocrinol Metab</source><year>2011</year><volume>55</volume><issue>3</issue><fpage>194</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1590/S0004-27302011000300004</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>AJ</given-names></name><name><surname>Taplin</surname><given-names>CE</given-names></name></person-group><article-title>Exercise in Youth with Type 1 Diabetes</article-title><source>Curr Pediatr Rev</source><year>2015</year><volume>11</volume><issue>2</issue><fpage>120</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.2174/1573396311666150702105340</pub-id><pub-id pub-id-type="pmid">26133177</pub-id></element-citation></ref></ref-list></back></article>